PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 28 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Chemically defined extracts from E. angustifolia roots showed no statistically significant effects on rhinovirus type 39 infection [PMID:16049208].
Evaluated as a supplement (combined with E. purpurea and vaginal hyaluronic acid) to boost viral clearance of HPV infection [PMID:35630063].
As part of the multicomponent formulation SAMITAL, it demonstrated clinical efficacy in reducing mucositis and pain in oncological patients [PMID:24156331].
Echinacoside, isolated from E. angustifolia, shows neuroprotective potential for Parkinson's and Alzheimer's diseases, though reliable clinical trials are scarce [PMID:29783690, PMID:37804927].
Safety & adverse effects
Pregnancy & lactation
Drug interactions
Evidence summary
PubMed sources
- 1.PMID: 30000869 (2006) — Treatment of the common cold in children and adults. · American family physician
- 2.PMID: 35567246 (2022) — Echinacea purpurea (L.) Moench: Biological and Pharmacological Properties. A Review. · Plants (Basel, Switzerland)
- 3.PMID: 37804927 (2023) — Echinacoside: A promising active natural products and pharmacological agents. · Pharmacological research
- 4.PMID: 16102249 (2005) — Echinacea species (Echinacea angustifolia (DC.) Hell., Echinacea pallida (Nutt.) Nutt.,Echinacea purpurea (L.) Moench): a review of their chemistry, pharmacology and clinical properties. · The Journal of pharmacy and pharmacology
- 5.PMID: 29783690 (2018) — Echinacoside, an Inestimable Natural Product in Treatment of Neurological and other Disorders.